atezolizumab and bevacizumab's function in treating liver cancer
Published 1 year ago • 379 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
3:42
imbrave050: adjuvant atezolizumab with bevacizumab in high-risk hcc
-
1:57
recent immunotherapy advances in hcc management
-
0:32
will atezolizumab and bevacizumab be the new soc in high-risk hcc?
-
5:12
safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
-
2:13
richard s. finn, md, offers opinion on the role of frontline atezolizumab bevacizumab in hcc
-
2:40
key outcomes of the phase 1b of atezolizumab and bevacizumab for advanced hcc
-
3:58
atezolizumab and bevacizumab for upfront unresectable hcc
-
3:44
atezolizumab bevacizumab in treatment-naïve mrcc
-
23:25
dr bharat | role of tecentriq atezolizumab avastin bevacizumab as 1l in unresectable hcc
-
4:03
real-world outcomes of patients with hcc treated with lenvatinib vs. atezolizumab plus bevacizumab
-
35:59
panel discussion | dr p n rao | managing patients with atezolizumab bevacizumab
-
0:37
combination atezolizumab plus bevacizumab improved quality of life in hcc
-
0:49
dr. kaseb on safety profile of atezolizumab plus bevacizumab in hcc
-
3:53
improvement in rfs for atezolizumab plus bevacizumab vs active surveillance without compromising qol
-
59:57
exploring new treatment options in hcc
-
1:30
dr. overman on the combination of atezolizumab and bevacizumab in hcc
-
3:05
richard s. finn, md, tells us about the safety profile of atezolizumab & bevacizumab from imbrave150
-
1:03
dr. pishvaian discusses atezolizumab plus bevacizumab in hcc